Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic graft-versus-hepatoblastoma effect.

Hiroto Inaba1, Rupert Handgretinger, Wayne Furman

  • 1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Pediatric Blood & Cancer
|April 5, 2005
PubMed
Summary

A patient with recurrent hepatoblastoma experienced tumor regression after unrelated donor stem cell transplant. Disease recurrence coincided with the resolution of graft-versus-host disease, suggesting an anti-tumor immune response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study.

The Lancet. Haematology·2026
Same author

Presentation and management of pediatric T-cell acute lymphoblastic leukemia with mediastinal mass and hyperleukocytosis.

Haematologica·2026
Same author

G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients.

Clinical biochemistry·2026
Same author

Blinatumomab in pediatric acute lymphoblastic leukemia: current and future use.

Leukemia·2026
Same author

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma.

Pharmacotherapy·2026
Same author

Association of neuropathy, sarcopenia and physical function in acute lymphoblastic leukemia survivors with chemotherapy alone.

Journal of cancer survivorship : research and practice·2026

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Hepatoblastoma survival rates have improved, but prognosis remains poor for unresectable and chemotherapy-refractory cases.
  • Novel therapeutic strategies are needed for advanced pediatric hepatoblastoma.

Observation:

  • A patient with recurrent metastatic hepatoblastoma received a non-myeloablative, HLA-matched unrelated donor stem cell transplant.
  • Tumor regression and decreased alpha-fetoprotein levels were observed following immunosuppression withdrawal and T-cell engraftment.
  • Disease recurrence occurred concurrently with the resolution of graft-versus-host disease (GVHD).

Findings:

  • The patient's clinical course suggests a potential graft-versus-hepatoblastoma effect.
  • The onset and resolution of GVHD correlated with tumor response and recurrence, respectively.

Related Experiment Videos

  • This case provides evidence for an immune-mediated anti-tumor response in hepatoblastoma.

    • Implications:

    • This case highlights the potential of allogeneic stem cell transplantation in treating refractory hepatoblastoma.
    • Further research into harnessing graft-versus-tumor effects could lead to new treatment paradigms.
    • Understanding the interplay between GVHD and anti-tumor immunity is crucial for optimizing stem cell transplant outcomes.